TL;DR: Amsterdam’s Healthplus.ai Secures €2.3M to Predict Post-Surgery Infections
Healthplus.ai, an Amsterdam-based healthtech startup, raised €2.3M in funding to scale PERISCOPE, its AI platform designed to predict and reduce post-surgery infection risks using real-time patient data from hospital electronic health records (EHRs). Key lessons include focusing on regulatory compliance, tackling urgent problems, and proving ROI to attract investors.
• Why it matters: Post-surgical infections affect 1 in 3 patients annually, highlighting the urgent need for solutions like PERISCOPE.
• Business insights: Aligning with regulatory requirements and demonstrating clear financial and clinical benefits were critical to securing investor confidence.
• Next steps: Funds will be used for global expansion, FDA certification, and refining predictive models for better healthcare outcomes.
For a deeper dive into healthtech startup strategies, read The Business Lessons from Healthplus.ai's Funding Success. Look here for inspiring insights into scaling responsibly in regulated markets!
Check out other fresh news that you might like:
AI Startup News: How to Boost Visibility in 2026 with These Game-Changing Tips
Startup News: Key Lessons and Tips from How Capital Flows in 2025 Shape Strategies for 2026
Startup News: Key Updates and Benefits of Zapier Automation Tools in 2026
In the competitive field of healthtech, where innovative solutions are constantly reshaping patient care, Amsterdam-based startup Healthplus.ai has successfully raised €2.3 million to scale its AI platform, PERISCOPE. The company’s mission is crystal clear: reduce post-surgery infection risks through predictive analytics, ultimately improving patient outcomes and cutting hospital costs. But beyond the funding news, there are important business lessons for entrepreneurs who want to play in this space, or any regulated market.
What is Healthplus.ai, and why does it matter?
Healthplus.ai has developed PERISCOPE, an ISO and CE-certified AI system that uses hospital electronic health records (EHRs) to predict surgical site infection risks for individual patients. The tool provides real-time, actionable insights tailored to specific patients, enabling clinicians to take preventive measures before complications occur. With roughly 1 in 3 surgical patients facing post-surgery complications annually, this is not a nice-to-have but an urgent necessity for modern healthcare systems.
As a serial entrepreneur, I was struck by how this company has managed not only to clear regulatory hurdles but also to position their product as indispensable rather than optional. Many startups struggle with proving their value proposition, and Healthplus.ai has done it by addressing a universal issue with tangible financial and human health benefits.
How did they manage to secure €2.3M in funding?
The funding round, led by Elevating Capital and supported by other names like LUMO Labs and Pathena, highlights investor confidence in Healthplus.ai’s ability to scale. A key factor in this success was their regulatory readiness, something many healthtech startups underestimate. According to Dr. Bart Geerts, the CEO of Healthplus.ai, their focus on achieving clinical validation and gaining certifications early in the product lifecycle played a significant role in attracting investors.
- They prioritized ISO and CE certification for European markets, signaling regulatory compliance.
- They demonstrated a clear value proposition: saving hospitals money, reducing infections, and improving patient recovery.
- They made a strategic push to integrate with leading EHR providers such as Epic, Cerner, and ChipSoft.
This methodical, data-driven approach serves as a roadmap for entrepreneurs looking to enter highly regulated industries where credibility often trumps speed.
What are the business and market implications?
Healthplus.ai is not just addressing a problem; it is redefining the approach toward surgical complications. Hospitals, which face financial, reputational, and operational risks from surgical infections, can ill afford to ignore such tools in the long run. Here’s why:
- Cost savings: Post-surgical infections cost healthcare systems billions annually. Early intervention not only prevents medical expenses but also reduces legal liabilities.
- Healthcare transformation: AI-enabled systems like PERISCOPE are part of a broader trend of real-time, data-driven medical interventions.
- Scalability and partnerships: By targeting global expansion and aiming for FDA certification for the U.S. market, Healthplus.ai has set a high water mark for scaling responsibly.
Entrepreneurs should take note: markets value solutions that integrate seamlessly into workflows while addressing systemic inefficiencies. By aligning product development with real-world clinical problems, Healthplus.ai stands out amidst a crowded playing field.
What are the key takeaways for founders?
Here are the lessons you can learn from Healthplus.ai’s journey:
- Tackle real, urgent problems: Don’t build a “nice-to-have” product. Solve something hospitals, businesses, or consumers can’t afford to ignore.
- Plan for regulatory hurdles early: Clinical validation, certifications, and compliance might seem like delays but are critical to success in healthcare.
- Prove your value: Show how your product saves money or delivers ROI (return on investment) through clear metrics, even better if it improves lives too.
- Build partnerships strategically: Integration with major systems like EHR platforms can open countless doors.
If you’re entering a field like healthtech, keep these principles in mind. They’ll likely make the difference between you being another failed startup vs. the next big success story.
How will this funding change the future?
Healthplus.ai intends to use the €2.3M not just for growth but for precision. Their roadmap involves entering new geographic markets, gaining additional certifications like FDA approval for entry into the U.S., and expanding their predictive models beyond infection risks. By focusing on scalability backed by thorough clinical validation, they’re setting themselves up for long-term success.
For entrepreneurs, this should be a wake-up call. Funding isn’t just about scaling, it’s about scaling responsibly while staying laser-focused on the real needs of your market. The “move fast and break things” mantra might work in software, but not when lives are on the line.
Final thoughts: What’s in it for you?
If you’re a founder or startup enthusiast, Healthplus.ai’s story offers valuable lessons. Focus on solving urgent, high-impact problems. Build trust through validation and certifications. Plan for regulatory and market hurdles because ignoring them is never an option. And finally, never lose sight of the humans behind the numbers, patient outcomes, hospital systems, and healthcare professionals.
As I always say, startups in regulated spaces must embrace a different kind of risk-taking: the kind that doesn’t seek to evade regulations but embraces them as part of proving the legitimacy of their solutions. Healthplus.ai is a textbook case, and one worth watching as they continue to grow. Let this be your inspiration today. Go tackle the hard stuff, it’s worth it.
FAQ on Healthplus.ai’s €2.3M Funding and AI Platform Expansion
What is Healthplus.ai, and how does it aim to revolutionize healthcare?
Healthplus.ai is an Amsterdam-based healthtech startup focused on reducing post-surgical infection risks through its AI platform, PERISCOPE. This platform analyzes electronic health records (EHRs) to provide real-time, patient-specific infection risk assessments, enabling clinicians to intervene proactively and improve recovery outcomes. This innovation addresses the global healthcare need, as one in three surgical patients currently experiences complications annually.
Learn about the accelerator pathways helping startups like Healthplus.ai scale innovations
How did Healthplus.ai secure €2.3 million in funding at the seed stage?
Healthplus.ai set itself apart by ensuring its PERISCOPE platform obtained CE and ISO certifications, validating its compliance with European healthcare regulations. The company also focused on clinical validation and demonstrated a clear value proposition, saving hospital costs and improving patient care. The funding round, led by Elevating Capital and co-supported by LUMO Labs, Pathena, and others, shows the importance of regulatory readiness in investor confidence.
Explore critical startup skills for founders leveraging AI healthcare innovations
Who are the key investors in Healthplus.ai's funding round?
The funding round featured significant names like Elevating Capital as the lead investor, alongside others such as LUMO Labs, ROM InWest, and Pathena. Collectively, these investors bring extensive experience in scaling healthtech businesses, regulatory approvals, and international expansion. The funding demonstrates a clear belief in Healthplus.ai’s scalability and compliance-based growth model.
What are the key features of the PERISCOPE platform?
The PERISCOPE platform is a certified AI decision-support tool that evaluates patient EHR data to predict post-surgery infection risk. Key features include real-time risk category segmentation, seamless integration with leading EHR platforms such as Epic and Cerner, and actionable clinical insights tailored to individual hospital workflows. This ensures doctors can intervene at the earliest signs of potential complications.
Why is AI in healthtech important, and what role does it play in European startups?
Healthcare systems globally suffer from inefficiencies caused by delayed interventions and high operational costs. AI-based platforms like PERISCOPE, driven by predictive analytics, address these issues by providing actionable solutions for complications like surgical infections. Such innovations align with Europe’s strong emphasis on efficiency in healthcare through compliance and ethical AI.
Delve deeper into how European cities foster healthtech startup ecosystems
What sets Healthplus.ai apart from its competitors in the AI healthtech market?
By emphasizing regulatory approvals early in its journey, Healthplus.ai has cleared a path that many budding healthtech startups find hard to navigate. This ISO- and CE-certified approach aligns with Europe's stringent healthcare requirements, positioning them as a leader in implementing clinically safe solutions. Their solution also integrates seamlessly with widely used EHR systems, making it attractive for hospitals looking for efficient and user-friendly tools.
Find out which startup trends and innovations are driving success
What market expansion and next steps are planned for Healthplus.ai?
Healthplus.ai aims to use this funding for global expansion, particularly targeting regulated markets such as the United States (pending FDA approval). Additionally, the company plans to enhance its technology further, expanding the predictive capabilities of its AI models to identify additional perioperative risks.
How does the funding reflect the company’s long-term vision?
The €2.3 million raised will allow Healthplus.ai to move one step closer to its goal of transforming how hospitals approach patient care. Part of this effort includes pursuing FDA clearance for U.S. healthcare markets and partnering with hospitals to implement PERISCOPE globally. This responsible scaling approach aligns with its mission of reducing healthcare costs and improving patient outcomes.
What challenges do healthtech startups often face in scaling and acquisition of funds?
Healthtech startups like Healthplus.ai encounter obstacles such as navigating complex regulatory environments, obtaining proper healthcare certifications like CE or FDA, proving the clinical efficacy of innovative solutions, and ensuring seamless technology integration with existing hospital systems. Overcoming these barriers requires meticulous planning, collaboration with healthcare professionals, and a strong focus on regulatory adherence.
Learn to overcome startup challenges with the right resources for female founders
How can aspiring healthtech founders draw inspiration from Healthplus.ai’s success story?
The journey of Healthplus.ai offers critical lessons for healthtech startup founders: focus on innovative solutions addressing urgent healthcare problems, gain regulatory certifications early, build partnerships with key providers (like EHR systems), and showcase measurable impacts, such as reduced costs or better patient outcomes. Strategic alignment with regulatory paths is vital for building trust in modern healthcare.
Get inspired by the mindset changes necessary for entrepreneurial success in healthtech
About the Author
Violetta Bonenkamp, also known as MeanCEO, is an experienced startup founder with an impressive educational background including an MBA and four other higher education degrees. She has over 20 years of work experience across multiple countries, including 5 years as a solopreneur and serial entrepreneur. Throughout her startup experience she has applied for multiple startup grants at the EU level, in the Netherlands and Malta, and her startups received quite a few of those. She’s been living, studying and working in many countries around the globe and her extensive multicultural experience has influenced her immensely.
Violetta is a true multiple specialist who has built expertise in Linguistics, Education, Business Management, Blockchain, Entrepreneurship, Intellectual Property, Game Design, AI, SEO, Digital Marketing, cyber security and zero code automations. Her extensive educational journey includes a Master of Arts in Linguistics and Education, an Advanced Master in Linguistics from Belgium (2006-2007), an MBA from Blekinge Institute of Technology in Sweden (2006-2008), and an Erasmus Mundus joint program European Master of Higher Education from universities in Norway, Finland, and Portugal (2009).
She is the founder of Fe/male Switch, a startup game that encourages women to enter STEM fields, and also leads CADChain, and multiple other projects like the Directory of 1,000 Startup Cities with a proprietary MeanCEO Index that ranks cities for female entrepreneurs. Violetta created the “gamepreneurship” methodology, which forms the scientific basis of her startup game. She also builds a lot of SEO tools for startups. Her achievements include being named one of the top 100 women in Europe by EU Startups in 2022 and being nominated for Impact Person of the year at the Dutch Blockchain Week. She is an author with Sifted and a speaker at different Universities. Recently she published a book on Startup Idea Validation the right way: from zero to first customers and beyond, launched a Directory of 1,500+ websites for startups to list themselves in order to gain traction and build backlinks and is building MELA AI to help local restaurants in Malta get more visibility online.
For the past several years Violetta has been living between the Netherlands and Malta, while also regularly traveling to different destinations around the globe, usually due to her entrepreneurial activities. This has led her to start writing about different locations and amenities from the point of view of an entrepreneur. Here’s her recent article about the best hotels in Italy to work from.